National Comprehensive Cancer Network



About NCCN

NCCN Announces Leukemia Resource Line for Physicians

Free Service to Answer Patient-Oriented Questions

JENKINTOWN, PA, January 30, 2004 – The National Comprehensive Cancer Network (NCCN) is pleased to announce the new NCCN Leukemia Resource Line. Physicians seeking guidance from leading leukemia experts can now call 1-888-469-NCCN (6226) to get feedback on diagnosing and treating leukemia patients.

“NCCN is proud to be able to offer this new level of interaction to help support clinical decision-making and advance patient care,” said William T. McGivney, PhD, Chief Executive Officer of NCCN.

Expert guidance is available within 1-2 business days from members of the NCCN Acute Myeloid Leukemia Guidelines panel: Harry P. Erba, MD, PhD, Assistant Professor, University of Michigan Comprehensive Cancer Center; Margaret R. O`Donnell, MD, Associate Clinical Director, Division of Hematology/Bone Marrow Transplantation, City of Hope Cancer Center; and Martin S. Tallman, MD, Director, Hematologic Malignancy Program, Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Physicians can also e-mail their inquiries to LeukemiaResource@nccn.org.

For questions about NCCN or for interview information, please contact Kim Schwalje, Public Relations Specialist, at 215-690-0252.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital